Essenvia Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
13
Essenvia General Information
Description
Operator of an online research data platform intended to streamline medical device pre and post-launch regulatory workflow. The company's platform offers a dashboard for cross-functional collaboration coupled with features to manage initial and subsequent device modifications, regulatory workflow management and administrative processes, enabling clients to reduce the cost and time to bring medical devices to market.
Contact Information
Website
www.essenvia.comCorporate Office
- 21255 Burbank Boulevard
- Floor 10
- Los Angeles, CA 91367
- United States
Corporate Office
- 21255 Burbank Boulevard
- Floor 10
- Los Angeles, CA 91367
- United States
Essenvia Timeline
Essenvia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 01-Feb-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 07-Mar-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Dec-2020 | $1.3M | $1.3M | Completed | Startup | |
| 1. Accelerator/Incubator | 16-Apr-2018 | Completed | Startup |
Essenvia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Series A-7 | ||||||||
| Series A-6 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 820,451 | $0.000001 | 6% | $0.19 | $0.19 | 1x | $0.19 | 4.05% |
| Series A-5 | 463,153 | $0.000001 | 6% | $0.11 | $0.11 | 1x | $0.11 | 2.29% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Essenvia Patents
Essenvia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11921783-B1 | Systems and methods for extracting and combining xml files of an xfa document | Active | 20-Sep-2023 | ||
| US-12443655-B2 | Systems and methods for extracting and combining xml files of an xfa document | Active | 20-Sep-2023 | ||
| US-20250094492-A1 | Systems and methods for extracting and combining xml files of an xfa document | Active | 20-Sep-2023 | G06F16/84 |
Essenvia Signals
Essenvia Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alliance for SoCal Innovation | Venture Capital | Minority | ||
| Benhamou Global Ventures | Venture Capital | Minority | ||
| Core91 VC | Venture Capital | Minority | ||
| Dan Lok Ventures | Venture Capital | Minority | ||
| First Rays Venture Partners | Venture Capital | Minority |
Essenvia FAQs
-
When was Essenvia founded?
Essenvia was founded in 2018.
-
Where is Essenvia headquartered?
Essenvia is headquartered in Los Angeles, CA.
-
What is the size of Essenvia?
Essenvia has 26 total employees.
-
What industry is Essenvia in?
Essenvia’s primary industry is Other Healthcare Technology Systems.
-
Is Essenvia a private or public company?
Essenvia is a Private company.
-
What is Essenvia’s current revenue?
The current revenue for Essenvia is .
-
How much funding has Essenvia raised over time?
Essenvia has raised $6.78M.
-
Who are Essenvia’s investors?
Alliance for SoCal Innovation, Benhamou Global Ventures, Core91 VC, Dan Lok Ventures, and First Rays Venture Partners are 5 of 13 investors who have invested in Essenvia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process